184 related articles for article (PubMed ID: 38287354)
21. Clinical perspectives of rare ovarian tumors: clear cell ovarian cancer.
Fujiwara S
Jpn J Clin Oncol; 2023 Jul; 53(8):664-672. PubMed ID: 37288485
[TBL] [Abstract][Full Text] [Related]
22. Endometriosis does not confer improved prognosis in ovarian clear cell carcinoma: a retrospective study at a single institute.
Zhao T; Shao Y; Liu Y; Wang X; Guan L; Lu Y
J Ovarian Res; 2018 Jun; 11(1):53. PubMed ID: 29941051
[TBL] [Abstract][Full Text] [Related]
23. Influence of lymphadenectomy on survival and recurrence in patients with early-stage epithelial ovarian cancer: a meta-analysis.
Yang C; Zhang T; Gong A; Shi C
BMC Womens Health; 2023 Sep; 23(1):474. PubMed ID: 37667358
[TBL] [Abstract][Full Text] [Related]
24. Impact of Adjuvant Chemotherapy on FIGO Stage I Ovarian Clear Cell Carcinoma: A Systematic Review and Meta-Analysis.
Yin M; Yang J; Zhou H; Liu Q; Li S; Zhang X
Front Oncol; 2022; 12():811638. PubMed ID: 35656506
[TBL] [Abstract][Full Text] [Related]
25. Impact of lymphadenectomy on survival after recurrence in patients with advanced ovarian cancer without suspected lymph node metastasis.
Paik ES; Shim M; Choi HJ; Lee YY; Kim TJ; Lee JW; Kim BG; Bae DS; Choi CH
Gynecol Oncol; 2016 Nov; 143(2):252-257. PubMed ID: 27567053
[TBL] [Abstract][Full Text] [Related]
26. Effect of Endometriosis on the Prognosis of Ovarian Clear Cell Carcinoma: A Two-Center Cohort Study and Meta-analysis.
Kim HS; Kim MA; Lee M; Suh DH; Kim K; No JH; Chung HH; Kim YB; Song YS
Ann Surg Oncol; 2015 Aug; 22(8):2738-45. PubMed ID: 25680339
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of systematic lymphadenectomy in patients with ovarian cancer: A systematic review and meta-analysis.
AlMahdy AM; Elassall GM; Abdelbadee AY; Abd-Elkariem AY; Atef F; Ahmed IA; Sayed EG; Salah MA; Ali AK; Ragab EY; Abd Elazeem HAS; Saad MM; Shazly SA;
Eur J Obstet Gynecol Reprod Biol; 2021 Dec; 267():179-185. PubMed ID: 34814044
[TBL] [Abstract][Full Text] [Related]
28. Prognostic impact of pelvic and para-aortic lymphadenectomy on clinically-apparent stage I primary mucinous epithelial ovarian carcinoma: a multi-institutional study with propensity score-weighted analysis.
Yoshihara M; Kajiyama H; Tamauchi S; Iyoshi S; Yokoi A; Suzuki S; Kawai M; Nagasaka T; Takahashi K; Matsui S; Kikkawa F
Jpn J Clin Oncol; 2020 Feb; 50(2):145-151. PubMed ID: 31688935
[TBL] [Abstract][Full Text] [Related]
29. Staging Lymphadenectomy in Patients With Clear Cell Carcinoma of the Ovary.
Mueller JJ; Holzapfel M; Han CH; Santos K; Gunderson C; Moore K; Erickson B; Leath CA; Diaz E; Walsh C; Wethington SL; Dejbakhsh SZ; Barakat RR; Gardner GJ; Hyman DM; Soslow RA; Leitao MM
Int J Gynecol Cancer; 2016 Jan; 26(1):120-4. PubMed ID: 26509849
[TBL] [Abstract][Full Text] [Related]
30. The Significance of Radiotherapy in Ovarian Clear Cell Carcinoma: A Systematic Review and Meta-Analysis.
Zhuang Y; Yang H
Cancer Control; 2023; 30():10732748231179291. PubMed ID: 37236911
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic value of selective lymphadenectomy in interval debulking surgery for stage IIIc and IV epithelial ovarian cancer.
Song N; Gao Y
Int J Gynecol Cancer; 2019 May; 29(4):761-767. PubMed ID: 30850437
[TBL] [Abstract][Full Text] [Related]
32. Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.
Bryant A; Hiu S; Kunonga PT; Gajjar K; Craig D; Vale L; Winter-Roach BA; Elattar A; Naik R
Cochrane Database Syst Rev; 2022 Sep; 9(9):CD015048. PubMed ID: 36161421
[TBL] [Abstract][Full Text] [Related]
33. Does complete-staging lymphadenectomy improve survival outcomes in stage I endometrioid epithelial ovarian carcinoma? A multi-institutional retrospective study with propensity score-weighted analysis.
Yoshihara M; Tamauchi S; Iyoshi S; Kitami K; Uno K; Tano S; Matsui S; Kajiyama H
Jpn J Clin Oncol; 2021 Mar; 51(3):387-392. PubMed ID: 33253382
[TBL] [Abstract][Full Text] [Related]
34. The role of systematic pelvic and para-aortic lymphadenectomy in the management of patients with advanced epithelial ovarian, tubal, and peritoneal cancer: A systematic review and meta-analysis.
Tzanis AA; Antoniou SA; Zacharoulis D; Ntafopoulos K; Tsouvali H; Daponte A
Eur J Obstet Gynecol Reprod Biol; 2023 Jun; 285():198-203. PubMed ID: 37149928
[TBL] [Abstract][Full Text] [Related]
35. Adjuvant chemotherapy in patients with stage I endometrioid or clear cell ovarian cancer in the platinum era: a Surveillance, Epidemiology, and End Results Cohort Study, 2000-2013.
Oseledchyk A; Leitao MM; Konner J; O'Cearbhaill RE; Zamarin D; Sonoda Y; Gardner GJ; Long Roche K; Aghajanian CA; Grisham RN; Brown CL; Snyder A; Chi DS; Soslow RA; Abu-Rustum NR; Zivanovic O
Ann Oncol; 2017 Dec; 28(12):2985-2993. PubMed ID: 28950307
[TBL] [Abstract][Full Text] [Related]
36. Role of systematic lymphadenectomy as part of primary debulking surgery for optimally cytoreduced advanced ovarian cancer: Reappraisal in the era of radical surgery.
Eoh KJ; Lee JY; Yoon JW; Nam EJ; Kim S; Kim SW; Kim YT
Oncotarget; 2017 Jun; 8(23):37807-37816. PubMed ID: 27906676
[TBL] [Abstract][Full Text] [Related]
37. Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial.
Panici PB; Maggioni A; Hacker N; Landoni F; Ackermann S; Campagnutta E; Tamussino K; Winter R; Pellegrino A; Greggi S; Angioli R; Manci N; Scambia G; Dell'Anna T; Fossati R; Floriani I; Rossi RS; Grassi R; Favalli G; Raspagliesi F; Giannarelli D; Martella L; Mangioni C
J Natl Cancer Inst; 2005 Apr; 97(8):560-6. PubMed ID: 15840878
[TBL] [Abstract][Full Text] [Related]
38. Friend or foe? The prognostic role of endometriosis in women with clear cell ovarian carcinoma. A UK population-based cohort study.
Tranoulis A; Buruiana FH; Gupta B; Kwong A; Lakhiani A; Yap J; Balega J; Singh K
Arch Gynecol Obstet; 2022 May; 305(5):1279-1289. PubMed ID: 34468823
[TBL] [Abstract][Full Text] [Related]
39. Sentinel lymph node detection in early-stage ovarian cancer: a systematic review and meta-analysis.
Agusti N; Viveros-Carreño D; Grillo-Ardila C; Izquierdo N; Paredes P; Vidal-Sicart S; Torne A; Díaz-Feijoo B
Int J Gynecol Cancer; 2023 Oct; 33(10):1493-1501. PubMed ID: 37487662
[TBL] [Abstract][Full Text] [Related]
40. Venous thromboembolism during primary treatment of ovarian clear cell carcinoma is associated with decreased survival.
Diaz ES; Walts AE; Karlan BY; Walsh CS
Gynecol Oncol; 2013 Dec; 131(3):541-5. PubMed ID: 24041880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
